IVISIONWORKS CO.,LTD.

Accelerates social impact startups & develops digital therapeutics for cognitive rehabilitation.

469750 | KO

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: South Korea
Address:: 대전광역시 유성구 국제과학21로 54 -, 대전광역시
Website:: http://www.govw.co.kr/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

IVISIONWORKS CO., LTD. operates with a dual focus on social impact investment and digital healthcare. Through its accelerator arm, Visionworks Ventures, the company discovers, nurtures, and invests in early-stage impact startups and social ventures aligned with the UN Sustainable Development Goals (SDGs). It provides comprehensive support programs, including mentorship, business development education, and access to seed investment and global acceleration opportunities. Concurrently, its Visionworks Neurons division develops digital therapeutics, focusing on neuroplasticity-based cognitive rehabilitation solutions for conditions such as Mild Cognitive Impairment (MCI) and emotional-cognitive digital treatments for Autism Spectrum Disorder (ASD).

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for IVISIONWORKS CO.,LTD. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all IVISIONWORKS CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for IVISIONWORKS CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Nykode Therapeutics ASA Developing novel immunotherapies and vaccines for cancer with its antigen-targeting platform.	Norway	NYKD
Oculis Holding AG Clinical-stage biopharma developing non-invasive eye drops for sight-threatening diseases.	Switzerland	OCS
OLIPASS CORPORATION Biotech firm developing RNA therapeutics for diseases with its proprietary OPNA platform.	South Korea	244460
Oncocross Co.,Ltd. AI-powered biotech accelerating drug development for cancer and rare diseases.	South Korea	382150
Onconic Therapeutics Inc. Develops novel drugs for cancer and GI diseases, including a next-gen acid blocker.	South Korea	476060
OncoTherapy Science, Inc. Develops targeted cancer therapies and provides TCR repertoire analysis services.	Japan	4564
Onxeo Developing precision-guided therapeutics using small antibodies for complex diseases.	France	ALONX
Openedges Technology, Inc. Semiconductor IP provider of memory subsystem & AI platform IP for AI, HPC, and IoT SoCs.	South Korea	394280
Openjobmetis Employment agency providing staffing, recruitment, and HR services to companies and job seekers.	Italy	OJM
Open Up Group Inc. Provides staffing and outsourcing of engineers for global manufacturing, IT, and construction sectors.	Japan	2154